VTRS - Vertex Pharma drops amid concerns over trial design for pain drug
2023-11-15 13:59:19 ET
More on Vertex Pharma
- Vertex Pharmaceuticals Incorporated (VRTX) Jefferies Global Healthcare Conference Call Transcript
- Vertex Pharmaceuticals Incorporated (VRTX) Presents at UBS Biopharma Conference (Transcript)
- No Dividend, No Problem: Vertex Pharmaceuticals Continues To Compound Wealth
- Vertex Pharmaceuticals ends development of Phase 2 drug for AATD
- Vertex shares dip 2% as Q3 revenue, guidance falls shy of Street estimates
For further details see:
Vertex Pharma drops amid concerns over trial design for pain drug